IPTi in Mozambican Infants for Malaria Prevention
NCT00209794
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
1498
Enrollment
OTHER
Sponsor class
Conditions
Malaria
Interventions
DRUG:
Sulfadoxine-Pyrimethamine (Fansidar)
Sponsor
Hospital Clinic of Barcelona